Cargando…

Protective Effects of Astodrimer Sodium 1% Nasal Spray Formulation against SARS-CoV-2 Nasal Challenge in K18-hACE2 Mice

Strategies to combat COVID-19 require multiple ways to protect vulnerable people from infection. SARS-CoV-2 is an airborne pathogen and the nasal cavity is a primary target of infection. The K18-hACE2 mouse model was used to investigate the anti-SARS-CoV-2 efficacy of astodrimer sodium formulated in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Paull, Jeremy R. A., Luscombe, Carolyn A., Castellarnau, Alex, Heery, Graham P., Bobardt, Michael D., Gallay, Philippe A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8402925/ https://www.ncbi.nlm.nih.gov/pubmed/34452519 http://dx.doi.org/10.3390/v13081656

Ejemplares similares

Virucidal and antiviral activity of astodrimer sodium against SARS-CoV-2 in vitro
por: Paull, Jeremy R.A., et al.
Publicado: (2021)

Astodrimer sodium antiviral nasal spray for reducing respiratory infections is safe and well tolerated in a randomized controlled trial
por: Castellarnau, Alex, et al.
Publicado: (2022)

Topical Astodrimer Sodium, a Non-Toxic Polyanionic Dendrimer, Demonstrates Antiviral Activity in an Experimental Ocular Adenovirus Infection Model
por: Romanowski, Eric G., et al.
Publicado: (2021)

Comparative pathology of the nasal epithelium in K18-hACE2 Tg mice, hACE2 Tg mice, and hamsters infected with SARS-CoV-2
por: Yu, Pin, et al.
Publicado: (2022)

A phase 3, randomized, controlled trial of Astodrimer 1% Gel for preventing recurrent bacterial vaginosis
por: Schwebke, Jane R., et al.
Publicado: (2021)

A phase 2, double-blind, multicenter, randomized, placebo-controlled, dose‑ranging study of the efficacy and safety of Astodrimer Gel for the treatment of bacterial vaginosis
por: Waldbaum, Arthur S., et al.
Publicado: (2020)

Astodrimer sodium and bacterial vaginosis: a mini review
por: Mendling, Werner, et al.
Publicado: (2022)

Sodium Pyruvate Nasal Spray Reduces the Severity of Nasal Inflammation and Congestion in Patients with Allergic Rhinitis
por: Martin, Alain, et al.
Publicado: (2022)

Fatal Neurodissemination and SARS-CoV-2 Tropism in K18-hACE2 Mice Is Only Partially Dependent on hACE2 Expression
por: Carossino, Mariano, et al.
Publicado: (2022)

Post-infection treatment with the E protein inhibitor BIT225 reduces disease severity and increases survival of K18-hACE2 transgenic mice infected with a lethal dose of SARS-CoV-2
por: Ewart, Gary, et al.
Publicado: (2023)

Formulation of a Composite Nasal Spray Enabling Enhanced Surface Coverage and Prophylaxis of SARS‐COV‐2
por: Moakes, Richard J. A., et al.
Publicado: (2021)

Warmer ambient air temperatures reduce nasal turbinate and brain infection, but increase lung inflammation in the K18-hACE2 mouse model of COVID-19
por: Dumenil, Troy, et al.
Publicado: (2023)

Development of a physiologically relevant dripping analytical method using simulated nasal mucus for nasal spray formulation analysis()
por: Masiuk, Tina, et al.
Publicado: (2016)

On the Use and the Abuse of Nasal Sprays
por: Roy, Dunbar
Publicado: (1901)

Treatment of Allergic Rhinitis with Ectoine Containing Nasal Spray and Eye Drops in Comparison with Azelastine Containing Nasal Spray and Eye Drops or with Cromoglycic Acid Containing Nasal Spray
por: Werkhäuser, Nina, et al.
Publicado: (2014)

Safety in Rats of a Novel Nasal Spray Formulation for the Prevention of Airborne Viral Infections
por: Tanori, Mirella, et al.
Publicado: (2023)

Fluorescence-enabled evaluation of nasal tract deposition and coverage of pharmaceutical formulations in a silicone nasal cast using an innovative spray device
por: D'Angelo, Davide, et al.
Publicado: (2022)

Virucidal gargling and virucidal nasal spray
por: Kramer, Axel, et al.
Publicado: (2021)

Nasal Sprays: What Apparatus to Use
por: Brown, George
Publicado: (1894)

DNA Methylation Architecture of the ACE2 gene in Nasal Cells
por: Cardenas, Andres, et al.
Publicado: (2020)

A patient preference study that evaluated fluticasone furoate and mometasone furoate nasal sprays for allergic rhinitis
por: Yanez, Anahi, et al.
Publicado: (2016)

Safety and Pharmacokinetic Assessments of a Novel Ivermectin Nasal Spray Formulation in a Pig Model
por: Errecalde, Jorge, et al.
Publicado: (2021)

Neuroinvasion and Neurotropism by SARS-CoV-2 Variants in the K18-hACE2 Mouse
por: Seehusen, Frauke, et al.
Publicado: (2022)

DNA methylation architecture of the ACE2 gene in nasal cells of children
por: Cardenas, Andres, et al.
Publicado: (2021)

Comparative analysis of the dispersion quality of oxymetazoline nasal sprays
por: Gobyzov, Oleg A., et al.
Publicado: (2022)

Oxymetazoline Hydrochloride Combined With Mometasone Nasal Spray for Persistent Nasal Congestion (Pilot Study)
por: Rael, Efren L, et al.
Publicado: (2011)

Risk of contamination of nasal sprays in otolaryngologic practice
por: Aydin, Erdinc, et al.
Publicado: (2007)

The effect of xylometazoline spray for expansion of nasal cavity
por: Han, Jun-Sung, et al.
Publicado: (2013)

Stability of extemporaneously compounded amiloride nasal spray
por: Yellepeddi, Venkata, et al.
Publicado: (2020)

Evaluation of K18-hACE2 Mice as a Model of SARS-CoV-2 Infection
por: Moreau, Gregory Brett, et al.
Publicado: (2020)

Exploring the disruption of SARS-CoV-2 RBD binding to hACE2
por: Carter, Camryn, et al.
Publicado: (2023)

COVID-19 Treatments and Pathogenesis Including Anosmia in K18-hACE2 mice
por: Zheng, Jian, et al.
Publicado: (2020)

Effect of Nigella sativa Nasal Spray on the Treatment of Chronic Rhinosinusitis Without a Nasal Polyp
por: Rezaeian, Ahmad, et al.
Publicado: (2018)

Nasal sprayed particle deposition in a human nasal cavity under different inhalation conditions
por: Calmet, Hadrien, et al.
Publicado: (2019)

Visualization and Estimation of Nasal Spray Delivery to Olfactory Mucosa in an Image-Based Transparent Nasal Model
por: Seifelnasr, Amr, et al.
Publicado: (2023)

Liposomal Nasal Spray versus Guideline-Recommended Steroid Nasal Spray in Patients with Chronic Rhinosinusitis: A Comparison of Tolerability and Quality of Life
por: Eitenmüller, Anna, et al.
Publicado: (2014)

Quantitative proton nuclear magnetic resonance method for simultaneous analysis of fluticasone propionate and azelastine hydrochloride in nasal spray formulation
por: El-Masry, Amal A., et al.
Publicado: (2021)

Neuroinvasion and Encephalitis Following Intranasal Inoculation of SARS-CoV-2 in K18-hACE2 Mice
por: Kumari, Pratima, et al.
Publicado: (2021)

K18-hACE2 mice develop respiratory disease resembling severe COVID-19
por: Yinda, Claude Kwe, et al.
Publicado: (2020)

K18-hACE2 mice develop respiratory disease resembling severe COVID-19
por: Yinda, Claude Kwe, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_0bov1h636svqml53irlt3fhk8f